📖

ApoE (Apolipoprotein E)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-apoe
Related Entities
apoe
Metadata
slugproteins-apoe
entity_typeprotein
kg_node_idapoe
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (554)
mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration90%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction90%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides90%
related🧪APOE Isoform Expression Across Glial Subtypes90%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration81%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides81%
mentions🧫GWAS of plasma NfL in East Asian cohort80%
mentions🧫GWAS of composite biomarker score80%
mentions🧫GWAS of plasma pTau217 in East Asian cohort80%
mentions🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho80%
mentions🧫GWAS of plasma pTau181 in East Asian cohort80%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model80%
mentions🧫GWAS of plasma GFAP in East Asian cohort80%
mentions🧫KEEPS Continuation: Long-term effects of menopausal hormone 80%
mentions🧫APOE4 association with TDP-43 pathology in AD80%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides80%
mentions🧪Competitive APOE4 Domain Stabilization Peptides80%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi80%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau80%
mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#80%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection80%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%
related🧪Competitive APOE4 Domain Stabilization Peptides80%
related🧪APOE Isoform Conversion Therapy80%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy80%
related🧪APOE Isoform Expression Across Glial Subtypes80%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer80%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones80%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction80%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy80%
related🧪Competitive APOE4 Domain Stabilization Peptides80%
see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE80%
see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 80%
mentions🔬Lipid metabolism dysregulation and membrane integrity in Alz75%
see_also📖nct0550878975%
see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739275%
see_also📖remternetug-anti-amyloid-alzheimers75%
see_also📖UPenn Observational Research Repository (NCT04715399)75%
related🧫GWAS of plasma NfL in East Asian cohort72%
related🧫GWAS of composite biomarker score72%
related🧫GWAS of plasma pTau217 in East Asian cohort72%
related🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho72%
related🧫GWAS of plasma pTau181 in East Asian cohort72%
related🧫RBG treatment in ApoE-/- atherosclerosis mouse model72%
related🧫GWAS of plasma GFAP in East Asian cohort72%
related🧫KEEPS Continuation: Long-term effects of menopausal hormone 72%
related🧫APOE4 association with TDP-43 pathology in AD72%
mentions🧪APOE Isoform Conversion Therapy70%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy70%
mentions🔬What are the mechanisms underlying blood-brain barrier trans70%
mentions🔬What are the mechanisms underlying apoe4 structural biology 70%
mentions🧪APOE Isoform Expression Across Glial Subtypes70%
mentions🧫Real-world safety study of Lecanemab in Japanese AD patients70%
mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%
mentions🧫DDT/DDE exposure and cognitive function in Latina women70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫ApoE4 Function in Alzheimer's Disease70%
mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD70%
mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%
mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
mentions🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati70%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A70%
mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol70%
mentions🧫Viral Infections and Alzheimer's Disease — causal mecha70%
mentions📓SEA-AD Gene Expression Analysis: Microglia vs Neurons70%
mentions📓Aging Mouse Brain Atlas: Cross-Age Gene Expression Analysis70%
mentions📓Pathway Enrichment Analysis for AD Targets70%
mentions📓SEA-AD Allen Brain Cell Atlas Analysis70%
related🔬What are the mechanisms underlying mechanistic role of apoe 70%
related🔬What are the mechanisms underlying apoe4 structural biology 70%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%
related🧫Blood-Based Biomarker Panel for Early AD Detection70%
related🔬What are the mechanisms underlying apoe4 structural biology 70%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%
related🧫Blood-Based Biomarker Panel for Early AD Detection70%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
see_also🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%
see_also🧪APOE Isoform Conversion Therapy70%
see_also🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%
see_also🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction70%
see_also🧪Targeted APOE4-to-APOE3 Base Editing Therapy70%
see_also🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%
see_also🧪APOE4-Selective Lipid Nanoemulsion Therapy70%
see_also🧪Competitive APOE4 Domain Stabilization Peptides70%
see_also🧪APOE Isoform Expression Across Glial Subtypes70%
see_also📓SEA-AD Gene Expression Analysis: Microglia vs Neurons70%
see_also📓Aging Mouse Brain Atlas: Cross-Age Gene Expression Analysis70%
see_also📓Pathway Enrichment Analysis for AD Targets70%
see_also📓SEA-AD Allen Brain Cell Atlas Analysis70%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and70%
see_also📖APOE2 (Apolipoprotein E2)70%
see_also📖APOE3 (Apolipoprotein E3)70%
see_also📖APOE4 (Apolipoprotein E4)70%
related🔬Lipid metabolism dysregulation and membrane integrity in Alz67%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di65%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc65%
mentions🔬Senescent cell clearance as neurodegeneration therapy65%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas65%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread65%
mentions🔬What are the mechanisms underlying blood-brain barrier trans63%
related🧫Real-world safety study of Lecanemab in Japanese AD patients63%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%
related🧫DDT/DDE exposure and cognitive function in Latina women63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫ApoE4 Function in Alzheimer's Disease63%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD63%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%
related🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin63%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease63%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 63%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%
related🧫Sleep and Circadian Dysfunction as Driver of Neurodegenerati63%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A63%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol63%
related🧫Viral Infections and Alzheimer's Disease — causal mecha63%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration60%
see_also📖Exosomal Biomarkers in Neurodegeneration60%
see_also📖Exosomal miR-155 in Neurodegeneration60%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration60%
see_also📖Liquid Biopsy in Neurodegeneration60%
see_also📖Metabolomic Biomarkers in Neurodegeneration60%
see_also📖Neuroimaging Biomarkers for Neurodegeneration60%
see_also📖Synaptic Biomarkers in Neurodegeneration60%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl60%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 60%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)60%
see_also📖China Neurodegeneration Epidemiology60%
see_also📖DALY Methodology — Neurodegeneration60%
see_also📖Disease Progression & Staging in Neurodegeneration60%
see_also📖Economic Burden — Neurodegeneration60%
see_also📖European Neurodegeneration Epidemiology60%
see_also📖Familial vs Sporadic Neurodegeneration Comparison60%
see_also📖Global Neurodegeneration Epidemiology60%
see_also📖India Neurodegeneration Epidemiology60%
see_also📖Japan Neurodegeneration Epidemiology60%
see_also📖Manganese-Related Neurodegeneration (Manganism)60%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison60%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr60%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 60%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)60%
see_also📖Potential Impact Measures — Neurodegeneration60%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)60%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)60%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)60%
see_also📖Sleep Disorders in Neurodegeneration60%
see_also📖US Neurodegeneration Epidemiology60%
see_also📖acetylcholine-signaling-neurodegeneration60%
see_also📖Advanced Glycation End Products in Neurodegeneration60%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 60%
see_also📖Amylin Signaling in Neurodegeneration60%
see_also📖Antibody Therapy in Neurodegeneration60%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration60%
see_also📖Autosis Pathway in Neurodegeneration60%
see_also📖Axon Guidance Pathways in Neurodegeneration60%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration60%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain60%
see_also📖CaMKII Signaling Pathway in Neurodegeneration60%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration60%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration60%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration60%
see_also📖Cholinergic System Dysfunction in Neurodegeneration60%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat60%
see_also📖Neural Circuits in Neurodegeneration60%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration60%
see_also📖Computational Disease Models for Neurodegeneration60%
see_also📖Convergent Pathways in Neurodegeneration60%
see_also📖Copper Homeostasis in Neurodegeneration60%
see_also📖COVID-19 Neurodegeneration Mechanism60%
see_also📖Diffusion MRI (DTI) in Neurodegeneration60%
see_also📖Digital Phenotyping in Neurodegeneration60%
see_also📖Down Syndrome Neurodegeneration Pathway60%
see_also📖Dystrophic Neurites in Neurodegeneration60%
see_also📖Endocannabinoid System in Neurodegeneration60%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration60%
see_also📖Endosomal Sorting Defects in Neurodegeneration60%
see_also📖Endothelin Signaling Pathway in Neurodegeneration60%
see_also📖epigenetics-neurodegeneration60%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration60%
see_also📖FA2H-Associated Neurodegeneration Pathway60%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration60%
see_also📖Galectin-3 Mechanism in Neurodegeneration60%
see_also📖Gangliosides in Neurodegeneration60%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration60%
see_also📖GDNF Signaling Pathway in Neurodegeneration60%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration60%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration60%
see_also📖Glycosylation in Neurodegeneration60%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration60%
see_also📖Hippocampal Neurogenesis in Neurodegeneration60%
see_also📖Histone Modification Pathways in Neurodegeneration60%
see_also📖HMGB1 Signaling in Neurodegeneration60%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration60%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration60%
see_also📖IL-1 Signaling Pathway in Neurodegeneration60%
see_also📖Integrated Stress Response in Neurodegeneration60%
see_also📖interleukin-6-signaling-neurodegeneration60%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration60%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 60%
see_also📖Kidney-Brain Neurodegeneration Axis60%
see_also📖Lipid Dysregulation in Neurodegeneration60%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration60%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration60%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration60%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration60%
see_also📖Metal Homeostasis in Neurodegeneration60%
see_also📖Microglial Priming Pathway in Neurodegeneration60%
see_also📖MicroRNA Dysfunction in Neurodegeneration60%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration60%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration60%
see_also📖Mitochondrial Fusion in Neurodegeneration60%
see_also📖Molecular Chaperones in Neurodegeneration60%
see_also📖mTOR Signaling in Neurodegeneration60%
see_also📖mTOR Signaling Pathway in Neurodegeneration60%
see_also📖Neural Circuit Disruption in Neurodegeneration60%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N60%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati60%
see_also📖Neuronal Hyperexcitability in Neurodegeneration60%
see_also📖Neuropil Threads in Neurodegeneration60%
see_also📖Neurotensin Signaling in Neurodegeneration60%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration60%
see_also📖NF-kB Signaling Pathway in Neurodegeneration60%
see_also📖Nitric Oxide Signaling in Neurodegeneration60%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration60%
see_also📖Neuropeptide Y Signaling in Neurodegeneration60%
see_also📖NRF2 Signaling Pathway in Neurodegeneration60%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration60%
see_also📖Orexin Signaling in Neurodegeneration60%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration60%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration60%
see_also📖Paranodal Dysfunction in Neurodegeneration60%
see_also📖Paraptosis in Neurodegeneration60%
see_also📖Parthanatos in Neurodegeneration60%
see_also📖Pericyte Loss in Neurodegeneration60%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration60%
see_also📖PKR Pathway in Neurodegeneration60%
see_also📖PPAR Signaling Pathway in Neurodegeneration60%
see_also📖Prion Diseases in Neurodegeneration60%
see_also📖Prion-Like Spread in Neurodegeneration60%
see_also📖Prion Protein Metabolism in Neurodegeneration60%
see_also📖Progesterone Signaling Pathway in Neurodegeneration60%
see_also📖Prognostic Biomarkers in Neurodegeneration60%
see_also📖Protein Aggregation Comparison in Neurodegeneration60%
see_also📖Protein Aggregation Seeds in Neurodegeneration60%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration60%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su60%
see_also📖Purinergic Signaling in Neurodegeneration60%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener60%
see_also📖R-Loop Stress in Neurodegeneration60%
see_also📖RAN Translation in Neurodegeneration60%
see_also📖Retinal Degeneration Pathway in Neurodegeneration60%
see_also📖Ribosome Dysfunction in Neurodegeneration60%
see_also📖RNA Splicing in Neurodegeneration60%
see_also📖RNA-Targeted Therapies in Neurodegeneration60%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a60%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration60%
see_also📖Senescent Cell Clearance in Neurodegeneration60%
see_also📖Serotonergic Dysfunction in Neurodegeneration60%
see_also📖Sex Differences in Neurodegeneration60%
see_also📖Short Chain Fatty Acids in Neurodegeneration60%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration60%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration60%
see_also📖Sleep Dysfunction in Neurodegeneration60%
see_also📖SUMOylation in Neurodegeneration60%
see_also📖synaptic-vesicle-cycling-neurodegeneration60%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration60%
see_also📖T-Cell Dysfunction in Neurodegeneration60%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration60%
see_also📖Therapeutic Targets in Neurodegeneration60%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration60%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration60%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration60%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration60%
see_also📖Vagus Nerve Pathway in Neurodegeneration60%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio60%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio60%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen60%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration60%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer60%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones60%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement60%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation60%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy60%
mentions🧪Competitive APOE4 Domain Stabilization Peptides60%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 60%
mentions🧪APOE-TREM2 Interaction Modulation60%
mentions🧪APOE-Dependent Autophagy Restoration60%
mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization60%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting60%
related🧪APOE Isoform Conversion Therapy60%
related🧪APOE4-Selective Lipid Nanoemulsion Therapy60%
see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%
see_also📖ABCA2 Gene - ATP Binding Cassette Subfamily A Member 260%
see_also📖a2m60%
related🔬What are the mechanisms underlying blood-brain barrier trans56%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro55%
related🧪Noradrenergic-Tau Propagation Blockade55%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh55%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime55%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di55%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement54%
related🧪Pharmacological Enhancement of APOE4 Glycosylation54%
related🔬What are the mechanisms underlying mechanistic role of apoe 54%
related🧪APOE-TREM2 Interaction Modulation54%
related🧪APOE-Dependent Autophagy Restoration54%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization54%
related🧪Proteostasis Enhancement via APOE Chaperone Targeting54%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪Netrin-1 Gradient Restoration50%
mentions🧪Purinergic Signaling Polarization Control50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Extracellular Vesicle Biogenesis Modulation50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Microglial Purinergic Reprogramming50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Sphingolipid Metabolism Reprogramming50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches50%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪Membrane Cholesterol Gradient Modulators50%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪Senescence-Associated Myelin Lipid Remodeling50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
mentions🧪Phase-Separated Organelle Targeting50%
mentions🧪Cross-Seeding Prevention Strategy50%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🔬Analysis question not specified50%
mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio50%
mentions🧪Epigenetic Memory Reprogramming for Alzheimer's Disease50%
mentions🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu50%
mentions🧪Targeted Butyrate Supplementation for Microglial Phenotype M50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon50%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%
mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🧫s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice 50%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi50%
related🧫s:** - Compare uptake with/without magnetic particles using 50%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬Analysis question not specified50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%
see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat50%
see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial50%
see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)50%
see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial50%
see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717050%
see_also📖UB-311 Alzheimer's Vaccination Trial50%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06745%
mentions🔬What are the mechanisms underlying apoe4 structural biology 42%
mentions🔬Analyze circuit-level changes in neurodegeneration using All40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪Netrin-1 Gradient Restoration40%
related🧪Purinergic Signaling Polarization Control40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪Multi-Modal Stress Response Harmonization40%
related🧪Complement C1q Mimetic Decoy Therapy40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪LRP1-Dependent Tau Uptake Disruption40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪Extracellular Vesicle Biogenesis Modulation40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪SASP-Mediated Complement Cascade Amplification40%
related🧪Complement C1q Subtype Switching40%
related🧪Microglial Purinergic Reprogramming40%
related🧪Autophagosome Maturation Checkpoint Control40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪Synaptic Vesicle Tau Capture Inhibition40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%
related🧪Lipid Droplet Dynamics as Phenotype Switches40%
related🧪Circadian-Synchronized LRP1 Pathway Activation40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪SASP-Driven Aquaporin-4 Dysregulation40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Stress Granule Phase Separation Modulators40%
related🧪Membrane Cholesterol Gradient Modulators40%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%
related🧪Senescence-Associated Myelin Lipid Remodeling40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Cross-Seeding Prevention Strategy40%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection40%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%
related🧪Trans-Synaptic Adhesion Molecule Modulation40%
mentions🔬What are the mechanisms underlying selective vulnerability o35%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp35%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%
mentions🔬What are the mechanisms underlying digital biomarkers and ai35%
mentions🔬What are the mechanisms underlying senolytic therapy for age35%
mentions🔬What are the mechanisms underlying neuroinflammation resolut35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬What are the mechanisms underlying what are the mechanisms b35%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli35%
mentions🔬What are the mechanisms underlying sleep disruption as cause35%
mentions🔬What are the mechanisms underlying rna binding protein dysre35%
mentions🔬What are the mechanisms underlying synaptic pruning by micro35%
mentions🔬What are the mechanisms underlying mitochondrial transfer be35%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%
mentions🔬What are the mechanisms underlying perivascular spaces and g35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬What gene expression changes in the aging mouse brain predic35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc35%
mentions🔬Investigate prion-like spreading of tau pathology through co35%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,35%
related🧪Proteostasis Enhancement via APOE Chaperone Targeting35%